On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queensland Trade Commissioner to Japan), and Ms. Annu Tamura (Senior Business Development Manager) to Hirotsu Bioscience headquarters in Tokyo.
During their visit, details of the progress that has been made on cancer-specific screening and the N-NOSE project in Japan were shared including progress on the large-scale clinical study for N-NOSE that is currently underway by QUT in Australia.
HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has recently . . .
2024.08.02In May 2024, the Indonesian healthcare company PT Jaya Prima Alkatra visited our company, and Press Release regarding this visit has been issued . . .
2024.08.01HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has conducted . . .
2024.07.24